EYE HEALTH AMERICA, LLC – Trademark Portfolio
Entity Type: 16
EYE HEALTH AMERICA, LLC holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 9 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include EYE HEALTH AMERICA, SEE THE DIFFERENCE, and UPDEGRAFF LASER VISION. The owner is based in Easley, SC.
15 Southern Center Court
Easley, SC 29642
Showing of trademarks Trademarks
Trademark Classifications
EYE HEALTH AMERICA, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does EYE HEALTH AMERICA, LLC have?
EYE HEALTH AMERICA, LLC has 15 U.S. trademarks filed with the USPTO. Of these, 4 registered, 4 abandoned, 7 cancelled.
What trademark classes does EYE HEALTH AMERICA, LLC file in?
EYE HEALTH AMERICA, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 35 (Advertising & Business). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.
What are EYE HEALTH AMERICA, LLC's most well-known trademarks?
EYE HEALTH AMERICA, LLC's registered trademark portfolio includes well-known marks such as EYE HEALTH AMERICA, SEE THE DIFFERENCE, and UPDEGRAFF LASER VISION. These are among 4 currently registered trademarks in the portfolio.
What is EYE HEALTH AMERICA, LLC's trademark registration success rate?
EYE HEALTH AMERICA, LLC has a 27% trademark registration rate, with 4 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.